Journal of Commercial Biotechnology — January 2010 issue now available
The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 16, Issue 1
Time for a new business model? (free full-text)
Yali Friedman
Why data exclusivity is the new patent protection
Peter Pitts
Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski and Elizabeth A Jex
Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb
Nigel Borshell and Adrian Dawkes
Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms
Mark J Ahn, Michael Meeks, Sally Davenport and Rebecca Bednarek
Intellectual property landscape and patenting opportunity in biofuels
Ramasamy Mannan
Challenges and opportunities in the licensing of renewable technologies
Meredith Lloyd-Evans, Mike Gilbert and Ilian P Iliev
Ethiopia: Biotechnology for development
Desta Berhe Sbhatu
Book Review: Health-care investing: Profiting from the new world of pharma, biotech and health-care services
Frank LaSaracina
Book Review: Aging, Biotechnology, and the Future
Harley King
Using IP audits to optimize IP assets
James G Cullem


07. Jan, 2010 













































One Response to “Journal of Commercial Biotechnology — January 2010 issue now available”